AIIMS building in Haryana's Jhajjar to be used exclusively to treat COVID-19 patients: ICMR Director-General
By ANI | Published: March 22, 2020 09:06 PM2020-03-22T21:06:52+5:302020-03-22T21:15:10+5:30
AIIMS building in Haryana's Jhajjar will be used exclusively to treat COVID-19 patients, the Indian Council of Medical Research (ICMR) Director-General Balram Bhargava said here on Sunday.
AIIMS building in Haryana's Jhajjar to be used exclusively to treat COVID-19 patients: ICMR Director-General
New Delhi [India], Mar 22 : AIIMS building in Haryana's Jhajjar will be used exclusively to treat COVID-19 patients, the Indian Council of Medical Research (ICMR) Director-General Balram Bhargava said here on Sunday.
"AIIMS building in Haryana's Jhajjar, which has 800 beds, will be used exclusively to treat COVID-19 patients," said Bhargava while addressing a press conference here.
"60 private labs have registered so far to conduct tests. Many of them are being approved as we speak," he said.
( With inputs from ANI )
Open in app